Renovare Therapeutics Overview

  • Year Founded
  • 2026

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Seed
  • (Upcoming)

  • Latest Deal Amount
  • $10M

  • Investors
  • 3

Renovare Therapeutics General Information

Description

Developer of regenerative therapeutics designed to treat musculoskeletal diseases, including osteoarthritis. The company offers particle-controlled drug delivery technologies, engineered biomaterials, and gene therapies for cartilage and bone tissue repair, enabling healthcare providers to deliver treatments that slow or reverse disease progression and restore joint function.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8871 Tahoe Court
  • Boulder, CO 80301
  • United States
+1 (919)
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Corporate Office
  • 8871 Tahoe Court
  • Boulder, CO 80301
  • United States
+1 (919)

Renovare Therapeutics Timeline

2027
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Renovare Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 29-Jan-2027 $10M Upcoming Pre-Clinical Trials
4. Seed Round 02-Oct-2026 Completed Pre-Clinical Trials
3. Accelerator/Incubator 18-May-2026 Completed Pre-Clinical Trials
2. Accelerator/Incubator 02-Apr-2026 Completed Pre-Clinical Trials
1. University Spin-Out 02-Apr-2026 Completed
To view Renovare Therapeutics’s complete valuation and funding history, request access »

Renovare Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Renovare Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innosphere Ventures Accelerator/Incubator
University of Colorado, Boulder Corporation Minority
Venture Partners at CU Boulder Accelerator/Incubator
To view Renovare Therapeutics’s complete investors history, request access »

Renovare Therapeutics FAQs

  • When was Renovare Therapeutics founded?

    Renovare Therapeutics was founded in 2026.

  • Where is Renovare Therapeutics headquartered?

    Renovare Therapeutics is headquartered in Boulder, CO.

  • What is the size of Renovare Therapeutics?

    Renovare Therapeutics has 1 total employees.

  • What industry is Renovare Therapeutics in?

    Renovare Therapeutics’s primary industry is Drug Discovery.

  • Is Renovare Therapeutics a private or public company?

    Renovare Therapeutics is a Private company.

  • What is Renovare Therapeutics’s current revenue?

    The current revenue for Renovare Therapeutics is .

  • How much funding has Renovare Therapeutics raised over time?

    Renovare Therapeutics has raised $100K.

  • Who are Renovare Therapeutics’s investors?

    Innosphere Ventures, University of Colorado, Boulder, and Venture Partners at CU Boulder have invested in Renovare Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process